Jesse Fann, MD, MPH
Mark N. Tabbutt Endowed Professorship for Education in Brain Health
Jesse Fann, MD, MPH, is the inaugural holder of the Mark N. Tabbutt Endowed Professorship for Education in Brain Health. In this role, Dr. Fann will direct a new Clinician Scientist Training Program (CSTP) that will identify, engage, and support trainees and junior faculty members who would like a mentored research experience and develop as clinician scientists. Dr. Fann leads the Department of Psychiatry and Behavioral Sciences’ Psychooncology program at the Fred Hutchinson Cancer Center and he has more than two decades of experience with conducting clinical research in the areas of psychooncology and traumatic brain injury, supported by numerous federal and foundation grants and resulting in over 150 peer reviewed research articles. He is looking forward to establishing and leading a program that will stimulate and support trainees and early-career faculty toward successful careers as clinician scientists.
Thomas J Grabowski, MD
Tim B. Engle Endowed Professorship for Brain Health Innovations
Thomas J Grabowski, MD, is the inaugural holder of the Tim B. Engle Endowed Professorship for Brain Health Innovations. In this role, Dr. Grabowski will help support the Institute’s efforts in the area of cognitive aging. This work will focus on strategies to promote brain wellness and resilience across the lifespan and to delay the effects of brain aging and degenerative brain diseases such as Alzheimer’s disease and other dementias.
Marco Pravetoni, PhD
Rick L. Seaver Endowed Professorship for Brain Wellness
Marco Pravetoni, PhD, is the inaugural holder of the Rick L. Seaver Endowed Professorship for Brain Wellness. Dr. Pravetoni is an expert in the development of vaccines, antibody-based strategies, and small molecules to counteract opioid use disorders and overdose, approaches that can improve the lives of individuals living with substance use disorders or who are at risk of fatal overdoses. Dr. Pravetoni will direct a new Center for Medication Development for Substance Use Disorders which will be located in the Research and Training (R&T) Building at Harborview Medical Center.